Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05541926 · ClinicalTrials.gov registry record · NA

Scaling up e-Connect in Juvenile Probation Settings

A NA study of Suicide, sponsored by New York State Psychiatric Institute.

Active
Registry status
NA
Development phase
3,629
Enrollment target
1
Study location

NCT05541926: Active NA study of Suicide, sponsored by New York State Psychiatric Institute.

NCT05541926 is a NA study of Suicide that is active but no longer recruiting, run by New York State Psychiatric Institute. The registered enrollment target is 3,629 participants, below the 6,950-participant average among 92 other Suicide trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05541926, a NA study of Suicide, is active but no longer recruiting, sponsored by New York State Psychiatric Institute.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
3,629 participants
Enrollment target
1
Study location

Study Summary

We propose to conduct research on strategies that support the successful scale-up of an evidence-based, suicidal risk and behavior identification and cross-system linkage programs for justice-involved youth (e-Connect), and to rigorously evaluate the implementation activities and associated costs that support that scale-up of e-Connect within 9 Indiana counties. Guided by the GPM and EPIS frameworks, this 4-year study will comprise 3 project phases: (1) Scale-Up Strategy Efforts, focused on preparing for scale-up; (2) e-Connect-scaleup implementation (2a Exploration and Preparation and 2b Implementation and Sustainment); and (3) Scale-Up Effectiveness Trial/Outcome Evaluation. The current project draws on lessons learned from the e-Connect efficacy trial in NYS and research team leadership will serve as External Facilitators to support 9 Local Facilitators to ensure the successful transfer of knowledge, skill and expertise in delivering e-Connect in a new JJ system and geographic context, utilizing implementation strategies to support the more widespread, sustained and rigorous adoption of e-Connect. The study will include a learning community created by External Facilitators for Local Facilitators to provide support, to exchange strategies to handle implementation issues, to develop competencies in facilitation, and to guide implementation throughout the program. The learning community will help Local Facilitators navigate through the implementation stages of the study.

Primary Outcome

Date of first behavioral health appointment/contact; extracted from Indiana Probation management information system (MIS)

Conditions Studied

Interventions

  • BEHAVIORAL e-Connect

Study Locations (1)

New York

  • Columbia University and New York State Psychiatric Instititute - New York

Trial Details

FieldValue
Enrollment Target 3,629 participants
Start Date 2023-05-02
Est. Completion 2027-08-31
Phase NA

What the registry record for NCT05541926 still lists

NCT05541926 is an interventional study that assigns participants to a tested intervention. Its 3,629 participants enrollment target places it among the larger protocols in the corpus, below the 6,950-participant average among 92 other Suicide trials with a reported enrollment target (48% lower).

The record links to 1 condition, with Suicide appearing as the primary indexed condition, and to 1 intervention - of which e-Connect is the first listed.

NCT05541926 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT05541926 about?

NCT05541926 is a clinical study titled "Scaling up e-Connect in Juvenile Probation Settings". We propose to conduct research on strategies that support the successful scale-up of an evidence-based, suicidal risk and behavior identification and cross-system linkage programs for justice-involved youth (e-Connect), and to rigorously evaluate the implementation activities and associated costs th...

What is the current status of trial NCT05541926?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 3,629 participants. The study started on 2023-05-02. Estimated completion is 2027-08-31.

What conditions does trial NCT05541926 study?

This clinical trial studies the following conditions: Suicide.

What interventions are being tested in trial NCT05541926?

The interventions under investigation include: e-Connect (BEHAVIORAL).

Who is sponsoring clinical trial NCT05541926?

This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05541926 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicide

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05541926's enrollment target sits among peer trials

3,629 7th of 92 higher than 86 of 92 other Suicide trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicide trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06354920 · 3,624 participants · NA

    M-Well Bonding Bundle to Improve Patient-Physician Relationships

  • NCT06702553 · 3,650 participants · Phase 3

    Nitric Oxide for Reduced Intensive Support in Cardiac Surgery With Cardiopulmonary Bypass

  • NCT07249398 · 3,650 participants · NA

    Influence of Social Media Ads on Food Choice - Master Protocol

  • NCT06088498 · 3,600 participants · Phase 2

    App for Reducing Cravings to Smoke

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05541926, the US trial registry maintained by the National Library of Medicine. NCT05541926 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.